Jun Wang
12 Papers
1 Citations
Jun Wang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 10 publications.
Chat about Author
Papers
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
Yuan Cheng,Chen-Yang He,Ding-Yuan Tian,Sida Chen,Jun-Rong Ren,Hao-Lun Sun,Man-Yu Xu,Cheng-Rong Tan,Dong-Yu Fan,Jie-Ming Jian,Pu-Yang Sun,Gui-Hua Zeng,Ying-Ying Shen,An-Yu Shi,Wang-Sheng Jin,Xian-Le Bu,Hongming Liu,Yu Ming Xu,Jun Wang,Yan-Jiang Wang +19 more
TL;DR: It is found that the liver physiologically clears blood Aβ and regulates brain Aβ levels, suggesting that a decline of hepatic Aβ clearance during aging could be involved in AD development, and hepaticAβ clearance is a novel therapeutic approach for AD.
50
A framework of biomarkers for brain aging: a consensus statement by the Aging Biomarker Consortium
Yusong Jia,Jun Wang,Jun-Rong Ren,P. Chang,Sheng Chen,Xiaochun Chen,Jagadish K. Chhetri,Junhong Guo,Qihao Guo,Lingjing Jin,Qiang Liu,Qiang Liu,Wenlin Ma,Zhiyong Mao,Moshi Song,Weihong Song,Yi Tang,Difei Wang,Peijun Wang,Lize Xiong,Keqiang Ye,Junjian Zhang,Weiqi Zhang,Xiaoqing Zhang,Yun-wu Zhang,Zhanjun Zhang,Zhuohua Zhang,Jialin C. Zheng,Yi E. Sun,Yan-Jiang Wang,Gang Pei +30 more
TL;DR: Wang et al. as discussed by the authors have combined the latest research results and practical experience to recommend brain aging biomarkers and form an expert consensus, aiming to provide a basis for assessing the degree of brain aging and conducting brain-aging-related research with the ultimate goal of improving the brain health of elderly individuals in both China and the world.
Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.
Xian-Le Bu,Pu-Yang Sun,Dong-Yu Fan,Jun Wang,Hao-Lun Sun,Ya Cheng,Gui-Hua Zeng,Dong-Wan Chen,Hui-Yun Li,Xu Yi,Ying-Ying Shen,Luke A. Miles,Paul Maruff,Ben J. Gu,Christopher Fowler,Colin L. Masters,Yan-Jiang Wang +16 more
TL;DR: It is suggested that CD22 plays important roles in AD development, and that sCD22 is a potential biomarker for AD.
9
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
Heleen M.M. van Beusekom,Xian-Le Bu,Gong Chen,Paulo Henrique Rosado de Castro,Xiaochun Chen,Xiaowei Chen,Andrew N. Clarkson,Tracy Farr,Jukka Jolkkonen,Woojin Scott Kim,Paula Korhonen,Shen Li,Yajie Liang,Guang‐Hui Liu,Guiyou Liu,Yu-Hui Liu,Tarja Malm,Xiaobo Mao,Mike M. Modo,Pedro Ramos‐Cabrer,Karsten Ruscher,Weihong Song,Jun Wang,Xuanyue Wang,Haitao Wu,Lize Xiong,Yi Yang,Keqiang Ye,Marietta Zille,Colin L. Masters,Piotr Walczak,Boltze Johannes,Yan‐Jiang Wang +32 more
TL;DR: The Alzheimer's Disease Neuroprotection Research Initiative's objective is to facilitate coordinated, multidisciplinary efforts to develop systemic neuroprotective strategies to combat AD, with the goal of halting or even reversing cognitive decline.
7
The time-dependent impact of type 2 diabetes mellitus on incident prodromal Alzheimer's disease: a longitudinal study in 1395 participants.
TL;DR: The authors investigated the longitudinal impact of type 2 diabetes mellitus (T2DM) on the prodromal and dementia stages of Alzheimer's disease (AD), focusing on diabetes duration and other comorbidities.
6